JUL 31, 2017 3:31 PM PDT

The Link Between BRCA Mutations and Prostate Cancer

WRITTEN BY: Xuan Pham

A study, published in the New England Journal of Medicine, examined DNA repair genes and whether mutations in these genes are highly prevalent in prostate cancer. They found that mutations in a gene commonly associated with breast cancer and ovarian cancer in women may also play a larger role in metastatic prostate cancer than doctors previously thought.

Image credit: Pixabay.com

The study results could mean a shift in how genetic testing is conducted for men with prostate cancer. In particular, men with the high-risk, metastatic form of the disease may want to be checked for heritable mutations that could be passed on to their children.

The team found that nearly 12 percent of the men were born with the DNA mutations associated with their cancer. This means a large proportion of these men inherited the DNA mutations from their parents. And in particular, mutations in the BRCA2 gene appeared in 5 percent of the men, making it the most commonly defective gene. Compared to men without prostate cancer, men with advanced prostate cancer were 18 times more likely to have a BRCA2 mutation.
 
The BRCA genes, also known as the Breast Cancer genes, are a well-known DNA repair genes in the context of breast and ovarian cancer. Mutations in this cancer duo account for 20 to 25 percent of all hereditary breast cancer types.


But while the perception of BRCA mutations has influenced the course of treatment for women at risk or battling breast cancer, the same mutations have yet to elicit a similar response for prostate cancer. And the research team hopes their study will change this.
 
"Our study has shown that a significant proportion of men with advanced prostate cancer are born with DNA repair mutations -- and this could have important implications for patients,” said Johann de Bono, professor at the ICR, who led the study in the United Kingdom. "Genetic testing for these mutations could identify men with advanced prostate cancer who may benefit from precision treatment. We could offer these men drugs such as PARP inhibitors, which are effective in patients with certain DNA repair mutations and are showing important anti-tumour activity in ongoing clinical trials.

Prostate cancer is the most common form of cancer in men, a statistic that highlights the need for better screening tools for this half of the population. "As doctors, we all know patients who say their father and grandfather had this cancer. We need to do trials to evaluate this risk. Then we could look at preventive strategies," said de Bono.
 
Though it’s too early to recommend screening in all men, the team hopes this will one day be a routine assessment. "In future testing all men with advanced disease for these mutations might help select the most effective treatments for them,” said Iain Frame, professor at the Prostate Cancer UK.
 


Additional source: Institute of Cancer ResearchBBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 15, 2020
Cancer
How is mole growth really associated to skin cancer?
OCT 15, 2020
How is mole growth really associated to skin cancer?
New research published in the journal eLife questions the way we think about skin cancer. Focused on mole growth, the st ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
NOV 23, 2020
Cancer
Platelets May Protect Cancer Against PD-1 Therapies
NOV 23, 2020
Platelets May Protect Cancer Against PD-1 Therapies
One of cancer’s greatest tools is its ability to manipulate the immune system. Many cancer therapies have arisen t ...
NOV 20, 2020
Cancer
How does tissue geometry influence cancer cellular migration?
NOV 20, 2020
How does tissue geometry influence cancer cellular migration?
A team of researchers led by UC Santa Barbara's Distinguished Professor Denise Montell has recently published new fi ...
NOV 29, 2020
Cell & Molecular Biology
Engineering 'Smart' Cells to Kill Cancer
NOV 29, 2020
Engineering 'Smart' Cells to Kill Cancer
Cancer researchers have long been searching for a way to target cancer cells while ignoring healthy cells. A team of sci ...
Loading Comments...